A detailed history of Ogorek Anthony Joseph transactions in Moderna, Inc. stock. As of the latest transaction made, Ogorek Anthony Joseph holds 612 shares of MRNA stock, worth $30,777. This represents 0.03% of its overall portfolio holdings.

Number of Shares
612
Previous 612 -0.0%
Holding current value
$30,777
Previous $65,000 10.77%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$85.37 - $115.44 $29,025 - $39,249
340 Added 125.0%
612 $65,000
Q4 2023

Feb 09, 2024

BUY
$69.51 - $104.43 $18,906 - $28,404
272 New
272 $27,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $19.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ogorek Anthony Joseph Portfolio

Follow Ogorek Anthony Joseph and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.